OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)

CUSIP: G6724L116

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
51,372,722
Total 13F shares
1,001,353
Share change
-9,559
Total reported value
$1,021,431
Price per share
$1.03
Number of holders
6
Value change
-$19,942
Number of buys
1
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G6724L116?
CUSIP G6724L116 identifies OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) as of Q3 2024

As of 30 Sep 2024, OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,001,353 shares. The largest 6 holders included BARCLAYS PLC, CITADEL ADVISORS LLC, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, and Continuum Advisory, LLC. This page lists 6 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.